Odyssean LLC’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.57M Buy
110,539
+50,534
+84% +$1.77M 0.41% 114
2026
Q2
$2.57M Buy
60,005
+39,495
+193% +$1.47M 0.42% 101
2026
Q1
$825K Buy
20,510
+13,014
+174% +$561K 0.3% 135
2025
Q4
$380K Buy
+7,496
New +$266K 0.27% 181

Other funds holding VERA

Odyssean LLC's VERA Position: Q3 2026 in Review

Odyssean LLC increased its Vera Therapeutics (VERA) stake by 84% in Q3 2026, buying an estimated $1.77M and bringing the position to 110,539 shares worth $3.57M. The position accounts for 0.41% of the portfolio, ranked #114.

Odyssean LLC first reported a position in VERA in Q4 2025 and has held it in 4 quarters since. 224 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • Odyssean LLC held 110,539 shares of Vera Therapeutics worth $3.57M as of Q3 2026.
  • Odyssean LLC bought 50,534 Vera Therapeutics shares in Q3 2026, an estimated $1.77M.
  • Vera Therapeutics made up 0.41% of Odyssean LLC's portfolio in Q3 2026, its #114 holding.
  • Odyssean LLC first reported a position in Vera Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • 224 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.